Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patientsSeres MbTx® platform ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
4don MSN
Antibodies' decoy tactics for outmaneuvering pathogens could inspire next-generation treatments
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
News-Medical.Net on MSN
New antibody mechanisms disrupt bacterial adhesion in urinary tract infections
Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...
Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives, today announced an agreement with Basilea Pharmaceutica Ltd, Allschwil ...
Scientists have found that antibodies stop UTI-causing E. coli by jamming or mimicking cell receptors, preventing bacterial ...
Allschwil, Switzerland Friday, January 9, 2026, 13:00 Hrs [IST] ...
Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today ...
About 130 years ago, American physician William Coley injected a terminally ill cancer patient with a lethal cocktail of ...
Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback